OXGN DDs! Huge!
1) Termination of $40M funding deal with Kingsbridge
You dont cancel funding unless something is brewing imo
2) Partnership deal or buyout or partnership by/with
Jerry McMahon Board Director @ OXiGENE, Inc.
Senior Vice President, R&D Oncology iMED Head @ MedImmune.
I would love to see a buyout through AZN.
The "AstraZeneca snares MedImmune (MEDI) in $15.6B buyout" article
looks very promising!
That might be the reason we see Jerry McMahon on the Board of
I am just speculating here but it looks very
3) New letter from OXGN CEO
...On the clinical front, shortly we expect to have the final
overall survival data from our completed Phase 2 study in non-small
cell lung cancer (the FALCON study) which compared the standard
chemotherapy treatment regimen for these patients, consisting
carboplatin, paclitaxel and bevacizumab with and without ZYBRESTAT.
We hope to be ready to talk about these results at our upcoming
quarterly earnings call in November 2011....
4) ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON OCTOBER 31,
5) OXGN chart signals:
Strong Volume Gainers
Moved Above Upper Bollinger Band
New CCI Buy Signals
Parabolic SAR Buy Signals
P&F Descending Triple Bottom Breakout